EBM and future directions of allergen-specific immunotherapy in atopic dermatitis

Japanese Journal of Allergology

Volumn 57, Issue 5, 2008, Pages 499-506

  Mihara, Shoji ^a   Hide, Michihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Allergen specific immunotherapy; Atopic dermatitis; House dust mite

Indexed keywords

ALLERGEN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; POLLEN ANTIGEN; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; DERMATOPHAGOIDES; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; VISUAL ANALOG SCALE; ANIMAL; DESENSITIZATION; DOUBLE BLIND PROCEDURE; FORECASTING; IMMUNOLOGY; METHODOLOGY; PYROGLYPHIDAE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANIMALS; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FORECASTING; HUMANS; IMMUNOGLOBULIN E; PYROGLYPHIDAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 44649098926     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Japanese source
2. Japanese source
3. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. ICCAD II Faculty. International Consensus Conference on Atopie Dermatitis II: clinical update and current treatment strategies. Br J Dermatol 2003; 148 (Suppl. 63): 3-10.
4. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergy and Clinical Immunology/ American Academy of Allergy, Asthma and Immunology / PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 153-69.
5. Japanese source
6. Nishioka K, Yasueda H, Saito H. Preventive effect of bedding encasement with microfine fibers on mite sensitization. J Allergy Clin Immunol 1998; 101 (1 Pt 1): 28-32.
7. Japanese source
8. Colloff MJ, Lever RS, McSharry C. A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations. Br J Dermatol 1989; 121: 199-208.
9. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15-8.
10. Friedmann PS, Tan BB. Mite elimination-clinical effect on eczema. Allergy 1998; 53 (48 Suppl): 97-100.
11. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 2000; 143: 379-84.
12. Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001; 145: 70-4.
13. Oosting AJ, de Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, de Monchy JG, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002; 110: 500-6.
14. Holm L, Bengtsson A, van Hage-Hamsten M, Ohman S, Scheynius A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration. Allergy 2001; 56: 152-8.
15. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, et al. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy 2005; 60: 888-93.
16. Japanese source
17. Strauss JS, Kligman A. The relationship between atopic allergy and dermatitis. Arch Dermatol 1957; 75: 806-11.
18. Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo controlled study. Ann Allergy 1974; 32: 321-30.
19. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; 2: 912-5.
20. Di Prisco de Fuenmayor MC, Champion RH. Specific hyposensitization in atopic dermatitis. Br J Dermatol 1979; 101: 697-707.
21. Ring J. Successful hyposensitization treatment in atopic eczema: results of a trial in monozy-gotic twins. Br J Dermatol 1982; 93: 597-602.
22. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992; 22: 440-6.
23. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG. Saint-Remy JM. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993; 28: 232-9.
24. Czarnecka-Operacz M, Silny W. Specific immunotherapy in atopic dermatitis. Acta Dermatovenerol Croat 2006; 14: 52-9.
25. Galli E, Chini L, Nardi S, Benincori N, Panei P, Fraioli G, et al. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol (Madr) 1994; 22: 18-22.
26. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997. Allergy 1998; 53 (44 Suppl): 1-42.
27. Petrova SI, Berzhets VM, Al'banova VI, Bystritskaia TF, Petrova NS. Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitization to house dust mites. Zh Mikrobiol Epidemiol Immunobiol 2001; 1: 33-6 (in Russian).
28. Silny W, Czarnecka-Operacz M, Silny P. Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score. Wiad Lek 2005; 58: 47-55 (in Polish).
29. Silny W, Czarnecka-Operacz M, Silny P. Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens. Wiad Lek 2005; 58: 184-92 (in Polish).
30. Silny W, Czarnecka-Operacz M, Silny P. Effectiveness of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part III. Serum concentrations of selected immunologic parameters. Wiad Lek 2005; 58: 287-94 (in Polish).
31. Silny W, Czarnecka-Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis-results of double blind placebo controlled study. Pol Merkur Lekarski 2006; 21: 558-65 (in Polish).
32. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006; 61: 202-5.
33. Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007; 120: 164-70.
34. Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007; 37: 1277-85.
35. Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006; 118: 1292-8.
36. Grewe M. Hyposensibilisierung beim atopischen Ekzem. Allergo J 2000; 9: 351-3 (in German).
37. Heijer A. Hyposensitzation with aeroallergens in atopic eczema. Allergo J 1993; 2: 3-7 (in German).
38. Pacor ML, Biasi D, Maleknia T. The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis. Recenti Prog Med 1994; 85: 273-7 (in Italian).
39. Trofimowicz A, Rzepecka E, Hofman J. Clinical effects of specific immunotherapy in children with atopic dermatitis. Rocz Akad Med Bialymst 1995; 40: 414-22.
40. Zachariae H, Cramers M, Herlin T, Jensen J, Kragballe K, Ternowitz T, et al. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985; 114: 48-54.
41. Seidenari S, Mosca M, Taglietti M, Manco S, Nume G. Specific hyposensitization in atopic dermatitis. Dermatologica 1986; 172: 229.
42. Mosca M, Albani-Rocchetti G, Vigini MA, Ubezio S, Nume G, Di Silverio A. La vaccinoterapia sulinguale nella dermatite atopica. Ital Dermatol Venerol 1993; 128: 79-83 (in Italian).
43. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 542-6.
44. Casanovas M, Martín R, Jiménez C, Caballero R, Fernández-Caldas E. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts. Clin Exp Allergy 2007; 37: 434-40.
45. Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 2007; 119: 826-30.
46. Crameri R, Rhyner C. Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 2006; 18: 761-8.
47. Nelson HS. Allergen immunotherapy: where is it now? J Allergy Clin Immunol 2007; 119: 769-79.